Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H25ClO5 |
| Molecular Weight | 392.873 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12C[C@H](O)[C@H]3[C@@H](C=C(Cl)C4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
InChI
InChIKey=YTJIBEDMAQUYSZ-FDNPDPBUSA-N
InChI=1S/C21H25ClO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7-8,12-13,16,18,23,25,27H,4,6,9-10H2,1-2H3/t12-,13-,16-,18+,19-,20-,21-/m0/s1
| Molecular Formula | C21H25ClO5 |
| Molecular Weight | 392.873 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6374803
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6374803
Cloprednol is a steroid, which was used for the treatment of asthma. The exact mechanism of cloprednol action is unknown. The drug was marketed under several names, including Syntestan and Cloradryn, however, its current marketing status is unknown and supposed to be discontinued.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6374803 |
Palliative | SYNTESTAN Approved UseAsthma. |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
41.3 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/660508/ |
2.5 mg single, oral dose: 2.5 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPREDNOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
426 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3403094/ |
20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPREDNOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
126 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/660508/ |
2.5 mg single, oral dose: 2.5 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPREDNOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1.87 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/660508/ |
2.5 mg single, oral dose: 2.5 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPREDNOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
16% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3403094/ |
20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered: |
CLOPREDNOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6374803
Cloprednol is given as a single morning dose of 5-12.5 mg orally.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:57:07 GMT 2025
by
admin
on
Wed Apr 02 09:57:07 GMT 2025
|
| Record UNII |
SYP56O3GJG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QH02AB14
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
||
|
WHO-ATC |
H02AB14
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
709
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
DB13843
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
100000084000
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL1697832
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
21285
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | RxNorm | ||
|
SYP56O3GJG
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
5251-34-3
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
m3657
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | Merck Index | ||
|
3566
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
Cloprednol
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
C011731
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
5284535
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
226-052-6
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
C80809
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
SUB06744MIG
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY | |||
|
DTXSID1022849
Created by
admin on Wed Apr 02 09:57:07 GMT 2025 , Edited by admin on Wed Apr 02 09:57:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |